These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1374546)

  • 21. [B cell population and its autoimmune activity in the thymus of patients associated with myasthenia gravis].
    Yoshitake T; Takahama T; Kanai F; Ohnishi K; Suzuki T; Kametani Y; Itoyama S; Sugawara I; Matsunaga A
    Kyobu Geka; 1993 Dec; 46(13):1083-7; discussion 1087-9. PubMed ID: 8258907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD5-positive B cells in type 1 (insulin-dependent) diabetic children.
    Lorini R; Massa M; d'Annunzio G; Cortona L; De Benedetti F; Martini A; Severi F
    Diabetes Res Clin Pract; 1993 Jan; 19(1):17-22. PubMed ID: 7682495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production of anti-acetylcholine receptor-alpha antibody in vitro by peripheral blood lymphocytes of patients with myasthenia gravis: role of immunoregulatory T cells and monocytes.
    Ofosu-Appiah W; Mokhtarian F; Shirazian D; Grob D
    J Lab Clin Med; 1994 Aug; 124(2):231-41. PubMed ID: 8051487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrathymic Tfh/B Cells Interaction Leads to Ectopic GCs Formation and Anti-AChR Antibody Production: Central Role in Triggering MG Occurrence.
    Zhang X; Liu S; Chang T; Xu J; Zhang C; Tian F; Sun Y; Song C; Yi W; Lin H; Li Z; Yang K
    Mol Neurobiol; 2016 Jan; 53(1):120-131. PubMed ID: 25407929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malignant B cell CD5 membrane phenotype and B cell colony growth in vivo and in vitro in patients with B-chronic lymphocytic leukemia: analysis with clinical parameters.
    Hings I; Kay NE; Ranheim E; Seroogy C; Parson RE
    Leuk Lymphoma; 1993 Dec; 12(1-2):59-67. PubMed ID: 7512855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD5 mRNA expression and auto-antibody production in early human B cells immortalized by EBV.
    Paavonen T; Quartey-Papafio R; Delves PJ; Mackenzie L; Lund T; Youinou P; Lydyard PM
    Scand J Immunol; 1990 Mar; 31(3):269-74. PubMed ID: 1690914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection.
    Zuckerman E; Slobodin G; Kessel A; Sabo E; Yeshurun D; Halas K; Toubi E
    Clin Exp Immunol; 2002 May; 128(2):353-8. PubMed ID: 11985527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ontogeny and functional characteristics of human B-1 (CD5+ B) cells.
    Bhat NM; Kantor AB; Bieber MM; Stall AM; Herzenberg LA; Teng NN
    Int Immunol; 1992 Feb; 4(2):243-52. PubMed ID: 1377947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyclonal B-cell activity in myasthenia gravis.
    Levinson AI; Dziarski A; Lisak RP; Zweiman B; Moskovitz AR; Brenner T; Abramsky O
    Neurology; 1981 Sep; 31(9):1198-1201. PubMed ID: 6973712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ectopic germinal centers, BAFF and anti-B-cell therapy in myasthenia gravis.
    Berrih-Aknin S; Ragheb S; Le Panse R; Lisak RP
    Autoimmun Rev; 2013 Jul; 12(9):885-93. PubMed ID: 23537509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune studies in human immunodeficiency virus infection with myasthenia gravis: a case report.
    Nath A; Kerman RH; Novak IS; Wolinsky JS
    Neurology; 1990 Apr; 40(4):581-3. PubMed ID: 2138717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of CD5 on B lymphocytes correlates with disease activity in patients with multiple sclerosis.
    Seidi OA; Semra YK; Sharief MK
    J Neuroimmunol; 2002 Dec; 133(1-2):205-10. PubMed ID: 12446024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human CD5+ B lymphocytes (B-1 cells) decrease in peripheral blood during pregnancy.
    Bhat NM; Mithal A; Bieber MM; Herzenberg LA; Teng NN
    J Reprod Immunol; 1995 Jan; 28(1):53-60. PubMed ID: 7537825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thymic B cells from myasthenia gravis patients are activated B cells. Phenotypic and functional analysis.
    Leprince C; Cohen-Kaminsky S; Berrih-Aknin S; Vernet-Der Garabedian B; Treton D; Galanaud P; Richard Y
    J Immunol; 1990 Oct; 145(7):2115-22. PubMed ID: 2144544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD5 positive B lymphocytes in schizophrenia: no alteration in numbers or percentage as compared with control subjects.
    Ganguli R; Rabin BS
    Psychiatry Res; 1993 Jul; 48(1):69-78. PubMed ID: 7692460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum Acetylcholine Receptor Antibodies Before the Clinical Onset of Myasthenia Gravis.
    Strijbos E; Verschuuren JJGM; Kuks JBM
    J Neuromuscul Dis; 2018; 5(2):261-264. PubMed ID: 29865092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The development and repertoire of B-1 cells (CD5 B cells).
    Kantor AB
    Immunol Today; 1991 Nov; 12(11):389-91. PubMed ID: 1723875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myasthenia gravis: studies on HL-A antigens and lymphocyte subpopulations in patients with myasthenia gravis.
    Hammarström L; Smith E; Möller E; Franksson C; Matell G; Von Reis G
    Clin Exp Immunol; 1975 Aug; 21(2):202-15. PubMed ID: 1081023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exogenous IL-9 Ameliorates Experimental Autoimmune Myasthenia Gravis Symptoms in Rats.
    Yao X; Zhao J; Kong Q; Xie X; Wang J; Sun B; Xu L; Mu L; Li H
    Immunol Invest; 2018 Oct; 47(7):712-724. PubMed ID: 29944018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapeutic strategy in myasthenia gravis].
    Tranchant C
    Rev Neurol (Paris); 2009 Feb; 165(2):149-54. PubMed ID: 19233080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.